Valeant CEO Seeks Acquisitions in High-Growth Health Care
This article is for subscribers only.
Valeant Pharmaceuticals International Inc., Canada’s largest drugmaker, said it is seeking acquisitions in opthalmology, dermatology and dentistry.
These areas “are growing faster than the overall growth rate of health care,” Chief Executive Officer Mike Pearson said in an interview on Bloomberg Television today.